Table 2.

Hazard ratios for overall and progression-free survival by temporalis muscle area group for in-house glioblastoma patient and TCGA-GBM data sets.

Patients	Univariate		Multivariate
	HR (95% CI)	p value	HR (95% CI)	p value
In-house glioblastoma patient data set—OS
CSA	0.444 (0.233–0.845)	0.013*	0.464 (0.218–0.988)	0.046*
Age	NA	NA	1.036 (1.002–1.070)	0.036*
Sex	NA	NA	1.430 (0.622–3.287)	0.399
In-house glioblastoma patient data set—PFS
CSA	0.367 (0.190–0.707)	0.003*	0.433 (0.218–0.860)	0.017*
Age	NA	NA	1.028 (0.998–1.059)	0.067
Sex	NA	NA	0.938 (0.436–2.014)	0.869
TCGA-GBM data set—OS
CSA	0.536 (0.299–0.961)	0.036*	0.466 (0.235–0.925)	0.029*
Age	NA	NA	1.029 (1.004–1.056)	0.025*
Sex	NA	NA	1.887 (0.918–3.880)	0.084

All figures are HR (95% CI).

OS overall survival, PFS progression-free survival, HR hazard ratio, CSA cross-sectional area, NA not applicable.

*Significant at p < 0.05.